EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Hepatitis C virus-related hepatitis flare after immunochemotherapy in a patient with follicular lymphoma

Yotaro Motomura, Kota Yoshifuji, Keisuke Tanaka, Chizuko Sakashita, Yoshihiro Umezawa, Toshikage Nagao, Sayuri Nitta, Yasuhiro Asahina, Takehiko Mori, Masahide Yamamoto

Journal of Clinical and Experimental Hematopathology · 2024

DOI: 10.3960/jslrt.24042 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2024. Verfasst von Yotaro Motomura und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan. Hauptthemen laut MEDLINE: Lymphoma, Follicular. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reactivation of hepatitis viruses during chemotherapy can be problematic in the treatment of malignant lymphomas. However, studies on reactivation of chronic hepatitis C virus (HCV) infection are limited. A 43-year-old woman presented with generalized lymphadenopathy and multiple liver tumors, and she was diagnosed with follicular lymphoma (grade 3a; clinical stage IV). Chronic HCV infection was clinically diagnosed. Immunochemotherapy (ICT), including bendamustine and obinutuzumab, was initiated with close liver function monitoring without specific treatment for hepatitis C. However, liver dysfunction worsened 17 days after ICT initiation, and ICT was interrupted. HCV-RNA and transaminase levels continued to elevate. Liver biopsy results confirmed acute exacerbation of chronic hepatitis C. Direct active antiviral (DAA) therapy was started and effective. She has maintained a sustained virologic response since DAA therapy ended. With regard to lymphoma, complete metabolic response was maintained for 4 years without additional treatment. Physicians should be aware of HCV reactivation with hepatitis flare after ICT for lymphoma and consider the indication and timing of DAA therapy for hepatitis C in this setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, FollicularHumansFemaleAdultHepatitis C, ChronicHepacivirusAntiviral AgentsBendamustine HydrochlorideAntineoplastic Combined Chemotherapy ProtocolsVirus ActivationImmunotherapyAntibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

bendamustinedirect-acting antiviralshepatitis C virus reactivationobinutuzumab

Substanzen

Antiviral AgentsBendamustine HydrochlorideobinutuzumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Hematology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.

Zitieren

APA

Motomura, Y., Yoshifuji, K., Tanaka, K., Sakashita, C., Umezawa, Y., Nagao, T., Nitta, S., Asahina, Y., Mori, T., & Yamamoto, M. (2024). Hepatitis C virus-related hepatitis flare after immunochemotherapy in a patient with follicular lymphoma. Journal of Clinical and Experimental Hematopathology. https://doi.org/10.3960/jslrt.24042

Vancouver

Motomura Y, Yoshifuji K, Tanaka K, Sakashita C, Umezawa Y, Nagao T, et al. Hepatitis C virus-related hepatitis flare after immunochemotherapy in a patient with follicular lymphoma. Journal of Clinical and Experimental Hematopathology. 2024. doi:10.3960/jslrt.24042

BibTeX
@article{Motomura2024,
  author = {Motomura, Yotaro and Yoshifuji, Kota and Tanaka, Keisuke and Sakashita, Chizuko and Umezawa, Yoshihiro and Nagao, Toshikage and Nitta, Sayuri and Asahina, Yasuhiro and Mori, Takehiko and Yamamoto, Masahide},
  title = {Hepatitis C virus-related hepatitis flare after immunochemotherapy in a patient with follicular lymphoma},
  journal = {Journal of Clinical and Experimental Hematopathology},
  year = {2024},
  doi = {10.3960/jslrt.24042}
}
Kostenlos starten →